Trial Profile
A Randomized, double-blind, placebo-controlled study on pharmacokinetics, pharmacodynamics and tolerability of multiple-dose Cenerimod in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Nov 2016
Price :
$35
*
At a glance
- Drugs Cenerimod (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 15 Nov 2016 New trial record